Methods of administering elagolix | Patent Publication Number 20200121680

US 20200121680 A1
Patent NumberUS 10682351 B2
Application Number16722741
Filled DateDec 20, 2019
Priority DateSep 1, 2015
Publication DateApr 23, 2020
Original AssigneeAbbvie Inc.
Current AssigneeAbbvie Inc.
Inventor/ApplicantsAhmed Salem
Cheri E. Klein
Sandra L. Goss
Juki Wing-Keung Ng
See the invalidated claims, subscribe to our Concierge Program.
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.